长风药业股份有限公司（02652）于2026年2月4日刊发翌日披露报表，宣布当日回购8,500股H股，涉及资金约29.56万港元，最高回购价每股35.16港元，最低回购价每股34.1港元。
本次回购股份占此前已发行股本约0.0028%。回购完成后，公司已发行股份数量由302,031,086股降至302,022,586股，同时库藏股数量由192,500股增至201,000股，合计发行股本总数保持302,223,586股不变。
公告显示，公司于2025年12月16日获得购回股份授权，可回购最高达30,222,358股。截至目前，公司已累计回购201,000股，占授权通过当日已发行股本0.0665%。公司强调已遵守上市规则及相关法律法规。
本次公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.